Estramustine
Emcyt (estramustine) is a small molecule pharmaceutical. Estramustine was first approved as Emcyt on 1982-01-01. It is used to treat prostatic neoplasms in the USA.
| Trade Name | Emcyt |
|---|---|
| Common Name | Estramustine |
| Indication | prostatic neoplasms |
| Drug Class | Antineoplastics (chloroethylamine derivatives); estrogens |
